Dr. Dipak Panigrahi is the Strategic Advisor to OTI Board. Dr. Panigrahi is a seasoned biotech executive and US-board certified ophthalmologist. He has 25 years of ophthalmology experience across clinical, regulatory, drug development and global medical affairs, along with his biotech business acumen. Prior to joining OTI, Dr. Panigrahi served as Chief Medical Officer of Amber Opthalmics, VP of Global Medical & Scientific Affairs at Sucampo, and VP of Pharmaceutical & Surgical Glaucoma at Alcon.
Copyright © OTI 2024 - All Rights Reserved.